Cryo Cell International Inc

CCEL

Exchange: NYSE
Industry: Services-Misc Health & Allied Services, NEC
SEC CIK: 0000862692

SEC filings (opens in a new tab)

No open-market purchases or sales by Cryo Cell International Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $1.77M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Cryo Cell International Inc changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of CCEL: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Q1 2022	Change
Holders	14	12	−2
Shares	903.5K	746.8K	−156.6K (−17.3%)
Value	$10.1M	$5.70M	−$4.43M (−43.8%)

New holders (1)

Institutions that held Cryo Cell International Inc at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to CCEL in Q1 2022
Institution	Shares	Value	% of portfolio
Advisor Group Holdings, Inc.	2,000	$15.0K	0.00%

Sold out (3)

Institutions that held Cryo Cell International Inc at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of CCEL in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
HighTower Advisors, LLC	13,761	$160.0K
Millennium Management LLC	12,741	$148.0K
Rowland & Co Investment Counsel	11,000	$127.6K